Science 37 Revenue and Competitors
Estimated Revenue & Valuation
- Science 37's estimated annual revenue is currently $61.9M per year.
- Science 37's estimated revenue per employee is $129,540
- Science 37's total funding is $347.5M.
Employee Data
- Science 37 has 478 Employees.
- Science 37 grew their employee count by -13% last year.
Science 37's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Executive Director, Business Development | Reveal Email/Phone |
3 | Executive Director Business Development | Reveal Email/Phone |
4 | Executive Director, Business Development & Global Strategic Accounts | Reveal Email/Phone |
5 | VP, FP&A | Reveal Email/Phone |
6 | VP, Information Technology & Engineering | Reveal Email/Phone |
7 | VP, Strategic Solutions/Commercial Operations | Reveal Email/Phone |
8 | Chief Legal & Human Resources Officer | Reveal Email/Phone |
9 | Director, Platform Engineering | Reveal Email/Phone |
10 | Chief Delivery Officer | Reveal Email/Phone |
Science 37 Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $91.2M | 513 | -5% | $506.6M | $2.1B |
What Is Science 37?
Science 37 is making the promise of virtual trials the new reality. By engaging with patients from the comfort of their own home, we provide access to patients who can never be reached by traditional site-based models. We have proven to enroll faster, retain patients at a higher rate, and reach a more representative population. Science 37 has conducted more decentralized, interventional trials than any other company, using an expansive, in-house network of telemedicine investigators and home-health nurses, who are supported by the industryￃﾢ￢ﾂﾬ￢ﾄﾢs most comprehensive, fully integrated, decentralized clinical trial platform.
keywords:saas
$347.5M
Total Funding
478
Number of Employees
$61.9M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Science 37 News
Science 37 (NASDAQ:SNCE) & ProMIS Neurosciences (OTCMKTS:ARFXF) Head to Head Contrast. Posted by admin on Apr 21st, 2022.
Comparatively, Science 37 has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Analyst Recommendations. This...
Financial Comparison: Science 37 (NASDAQ:SNCE) vs. Bioqual (OTCMKTS:BIOQ). Posted by admin on Apr 14th, 2022. Share on Twitter Share on Facebook Share on...
November 15 Science 37 Holdings, Inc. (Nasdaq: SNCE) today reported its financial results for the quarter ended September 30, 2021 LOS ANGELES, November 15, 2021 - Science 37 Holdings, Inc. (Nasdaq: SNCE), ("Science 37") the Operating System for today's more agile clinical trials, today report ...
Science 37 Reports Quarterly Financial Results for the Period Ended September 30, 2021 LOS ANGELES, November 15, 2021 - Science 37 Holdings, Inc. (Nasdaq: SNCE), ("Science 37") the Operating System for today's more agile clinical trials, today reported its financial results for the quarter ende ...
Other Companies in Los Angeles
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $122.7M | 479 | 3% | N/A |
#2 | $132M | 480 | -5% | N/A |
#3 | $133.7M | 486 | 8% | N/A |
#4 | $164M | 486 | 15% | N/A |
#5 | $124.8M | 487 | 2% | N/A |